Dexter wins a Red Dot Award 2020: An award-winning partnership with an award-winning robot.

Dexter’s unique approach to robotic surgery has been awarded a 2020 Red Dot Award. This is yet again a testimony to the ingenious work carried out by the Distalmotion team in close collaboration with our like-minded partner McKinsey Design. While robotic surgery is a health-care reality with promising benefits, widespread adoption of the technology has remained …

Dexter wins a Red Dot Award 2020: An award-winning partnership with an award-winning robot. Read More »

Dexter successful validation brings Distalmotion surgical robot one-step closer to commercialization

Dexter validation confirms Distalmotion surgical robot is safe for use and meets surgeons and nurses expectations Around 20 surgeons and 20 nurses from leading European hospitals, across urology, gynaecology and general surgery participated in Dexter validation end of February and early March 2020 Surgical teams successfully performed surgical procedures using Dexter, including draping, docking, suturing, …

Dexter successful validation brings Distalmotion surgical robot one-step closer to commercialization Read More »

From Singapore to Switzerland, there’s only one way to stop fraud

Craig Erickson, MD is Professor and psychiatrist at the Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine- Affiliated.  He brings 15 years of experience in clinical trials in the field of neurodevelopmental disorders (NDDs), including autism spectrum disorders (ASD). He is also the principal investigator of STALICLA’s STP1 trial. In this interview, …

From Singapore to Switzerland, there’s only one way to stop fraud Read More »

Swiss Biotech STALICLA Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A

GENEVA–(BUSINESS WIRE)–STALICLA SA, a near clinical stage Swiss Biotech company leading the field of precision medicine for Neurodevelopmental Disorders (NDDs) – including conditions like Autism Spectrum Disorder (ASD) or Developmental Delay – today announced the successful closure of the second tranche of its series A for an amount of USD 8M (CHF 7.7M). The round …

Swiss Biotech STALICLA Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A Read More »

LumiThera Adds Daniel Bertholet to Board of Directors

SEATTLE, Jan. 23, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has added Daniel Bertholet to the Board of Directors.  “We are very excited to have Daniel Bertholet join our Board of Directors,” stated Clark Tedford, Ph.D., President and CEO. …

LumiThera Adds Daniel Bertholet to Board of Directors Read More »

SOPHiA GENETICS Reaches New Analytical Heights with its Whole Exome Solution

SOPHiA Whole Exome Solution (WES) now includes accurate CNV detection, making it a powerful application for healthcare professionals in their fight against rare diseases. Houston, Texas, USA – 18th October 2019: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today at the American Society of Human Genetics Annual Meeting (ASHG) the release of the new version …

SOPHiA GENETICS Reaches New Analytical Heights with its Whole Exome Solution Read More »